Skip to main content

China

WINTIPAK Details Hong Kong Arbitration Award in Dispute With Greatview Holdings

Image
WINTIPAK Details Hong Kong Arbitration Award in Dispute With Greatview Holdings

SHERIDAN, WYOMING -- July 07, 2026 -- WINTIPAK AG has issued a public notice outlining the status of ongoing legal proceedings between itself and Greatview Holdings Ltd, a wholly owned subsidiary of Hong Kong-listed Greatview Aseptic Packaging Company Limited (GAPCL). The notice responds to a series of prior announcements from GAPCL and Shandong NewJF Technology Packaging Co., Ltd. describing court actions and arbitration filings against WINTIPAK and related parties. WINTIPAK's statement adds detail the company says was missing from those earlier disclosures, including an emergency arbitration award it obtained against Greatview Holdings before the other proceedings were filed. A Hong Kong High Court hearing on the matter is scheduled for May 19, 2026.

interpack China Expands SAVE FOOD Program Through New AIP Partnership Ahead of November Expo

Image
interpack China Expands SAVE FOOD Program Through New AIP Partnership Ahead of November Expo

SHERIDAN, WYOMING -- July 07, 2026 -- interpack China has confirmed a first-time partnership with the Australasian Institute of Packaging (AIP) as it builds out the SAVE FOOD China program for its sixth edition this November. The tie-up brings an established packaging education authority from Australia, New Zealand and Southeast Asia into direct collaboration with the Shanghai-based exhibition. Organizers announced the news alongside strong early pre-registration numbers and confirmed attendance from major food and packaging manufacturers. The moves position the November event as a broader meeting point for food-loss reduction efforts across the Asia-Pacific packaging supply chain.

Bauma Shanghai 2026 Adds Second Pudong Venue to Match Growth in China's Construction Machinery Sector

Image
Bauma Shanghai 2026 Adds Second Pudong Venue to Match Growth in China's Construction Machinery Sector

SHERIDAN, WYOMING -- June 7, 2026 -- Messe München will stage bauma Shanghai 2026 across two Pudong venues simultaneously, marking the first time the construction machinery trade fair has operated in a "one show, two venues" format. The Shanghai World Expo Exhibition & Convention Center runs from 23 to 26 November 2026, while the Shanghai New International Expo Centre operates from 24 to 27 November. Both sites run under a unified exhibition concept and product portfolio spanning construction machinery, building material machines, mining machines and construction vehicles. Komatsu, LiuGong and Sunward Intelligent are among the confirmed exhibitors, with booth applications from domestic and international companies described as having exceeded advance expectations.

Grandprint (Shengda) adds six HEIDELBERG Speedmaster CX 92 presses to scale China web-to-print packaging output

Image

SHERIDAN, WYOMING - March 17, 2026 - Grandprint (Shengda) has expanded its web-to-print operations by purchasing six additional Speedmaster CX 92 presses from Heidelberger Druckmaschinen AG (HEIDELBERG). The move continues what HEIDELBERG describes as a sustained investment cycle by the printer in digital and hybrid technologies from HEIDELBERG and Gallus. For commercial leaders and production managers, the purchase signals added conventional press capacity aligned with hybrid workflows, aimed at meeting demand patterns tied to packaging and label work in China. It also indicates continued capital deployment into equipment that can support web-to-print-driven order volumes and turnaround expectations.

BMS Signs $1B-Plus Multi-Specific Antibody Pact With China's Harbour BioMed

Image
BMS Signs $1B-Plus Multi-Specific Antibody Pact With China’s Harbour BioMed

SHERIDAN, WYOMING - December 19, 2025 - Bristol Myers Squibb (BMS) has struck a potential $1B-plus partnership with Harbour BioMed to collaborate on next-generation multi-specific antibody programs, underscoring how China-based innovation is increasingly shaping global biologics dealmaking.

Deal scope and economics in brief
BMS will pay $90 million upfront to work with Harbour on developing and advancing multi-specific antibody therapies, with additional development and commercial milestones that could total up to $1.035 billion. The partners did not disclose how many programs are covered, nor did they specify initial targets, indications, or therapeutic areas.

For business development teams and portfolio planners, the structure reflects a familiar "platform-plus-programs" model: BMS buys early discovery leverage and optionality, while Harbour positions itself for milestone upside and downstream royalties if programs progress.

Dubai Airshow 2025 Opens with COMAC C919 Making Middle East Debut as Chinese Aviation Presence Expands

Image
Dubai Airshow 2025 Opens with COMAC C919 Making Middle East Debut as Chinese Aviation Presence Expands

SHERIDAN, WYOMING - December 15, 2025 - Dubai Airshow 2025 opened at Dubai World Central with the Middle East debut of two of China's homegrown C919 aircraft, signaling a higher-profile push by Chinese aerospace players to showcase commercial, unmanned, and next-generation aviation technologies to global buyers.

C919 debut puts China's narrowbody on a new international stage
At the 19th edition of the Dubai Airshow, the appearance of the C919 marked its first showing in the Middle East, with a flight demonstration at the venue. The aircraft's presence matters beyond the air display: for airlines, lessors, MRO providers, and airport stakeholders, international showcases help shape early market perception around supply-chain maturity, support ecosystems, and longer-term export ambitions.

ARIDGE Unveils A868 Tilt-Rotor Hybrid Flying Car as Land Aircraft Carrier Factory Enters Trial Production

Image
ARIDGE Unveils A868 Tilt-Rotor Hybrid Flying Car as Land Aircraft Carrier Factory Enters Trial Production

SHERIDAN, WYOMING - December 15, 2025 - ARIDGE has introduced new details on its next-generation A868 flying car concept and confirmed fresh progress at its flying car manufacturing plant, as the company positions two flight systems to serve different segments of China's emerging low-altitude mobility market.

Two flight systems target distinct low-altitude travel needs
ARIDGE framed the low-altitude economy as the next major growth frontier following new energy vehicles, and outlined a dual-product strategy built around different operating missions. The company is developing:

XPENG AEROHT Starts Trial Production at Flying Car Plant, Marking Shift Toward Scaled eVTOL Manufacturing

Image
XPENG AEROHT Starts Trial Production at Flying Car Plant, Marking Shift Toward Scaled eVTOL Manufacturing

SHERIDAN, WYOMING - December 15, 2025 - XPENG AEROHT, the flying car affiliate of Chinese EV maker XPENG, has begun trial production at what it describes as the world's first intelligent factory for mass-produced flying cars-an operational milestone as next-generation mobility moves from prototypes to industrial output.

Trial production signals a commercialization inflection point
The company started trial production on November 3, 2025, positioning the facility as a bridge between engineering validation and repeatable manufacturing. For the broader eVTOL and "low-altitude mobility" ecosystem, factory readiness matters because it shifts the discussion from flight demonstrations to supply chains, quality systems, and scalable assembly-areas that typically determine whether new vehicle categories can reach customers on schedule.

Shanghai M&A Finance Conference Unveils New Deal Index and Multi-Institution Alliance to Accelerate Listed-Company Transactions

Image
Shanghai M&A Finance Conference Unveils New Deal Index and Multi-Institution Alliance to Accelerate Listed-Company Transactions

SHERIDAN, WYOMING - December 15, 2025 - Shanghai is sharpening its push to become a leading center for merger-and-acquisition activity, as the 2025 Mergers and Acquisitions Finance Conference spotlighted stronger regional deal momentum and unveiled a new market index intended to track China's evolving M&A environment.

Policy momentum behind listed-company restructuring
The conference took place as Shanghai marks one year since releasing a three-year action plan aimed at supporting M&A among listed firms. In practical terms, the message to corporate leaders and capital providers is clear: policy alignment and financial-market infrastructure are being positioned to support more transactions that improve efficiency, accelerate industrial upgrading, and strengthen competitiveness in key sectors.

Pfizer Deepens Cardiometabolic Push with Global YaoPharma Deal for Oral GLP-1 Candidate

Image
Pfizer Deepens Cardiometabolic Push with Global YaoPharma Deal for Oral GLP-1 Candidate

SHERIDAN, WYOMING - December 10, 2025 - Pfizer Inc. is expanding its cardiometabolic ambitions through an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical, to develop, manufacture and commercialize YP05002, an oral GLP-1 receptor agonist currently in Phase 1 for chronic weight management. The deal strengthens Pfizer's position in the fast-moving obesity field and adds a differentiated small-molecule asset to its portfolio of metabolic disease candidates.

Strategic Bet on Small-Molecule GLP-1 in Obesity

Under the agreement, China-based YaoPharma will complete an ongoing Phase 1 study of YP05002 before transferring global development and commercialization rights to Pfizer. For Pfizer, the asset fits neatly into a strategy that aims to pair novel mechanisms with scalable, oral delivery formats for obesity and adjacent cardiometabolic conditions.